BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29161070)

  • 1. Declines in Anogenital Warts Among Age Groups Most Likely to Be Impacted by Human Papillomavirus Vaccination, United States, 2006-2014.
    Flagg EW; Torrone EA
    Am J Public Health; 2018 Jan; 108(1):112-119. PubMed ID: 29161070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: potential impact of human papillomavirus vaccination.
    Flagg EW; Schwartz R; Weinstock H
    Am J Public Health; 2013 Aug; 103(8):1428-35. PubMed ID: 23763409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006-2014: The impact of human papillomavirus vaccination.
    Shing JZ; Hull PC; Zhu Y; Gargano JW; Markowitz LE; Cleveland AA; Pemmaraju M; Park IU; Whitney E; Mitchel EF; Griffin MR
    Papillomavirus Res; 2019 Jun; 7():141-149. PubMed ID: 30980966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a single-age cohort human papillomavirus vaccination strategy in Catalonia, Spain: Population-based analysis of anogenital warts in men and women.
    Brotons M; Monfil L; Roura E; Duarte-Salles T; Casabona J; Urbiztondo L; Cabezas C; Bosch FX; de Sanjosé S; Bruni L
    Prev Med; 2020 Sep; 138():106166. PubMed ID: 32565118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The early impact of human papillomavirus vaccination on anogenital warts in Québec, Canada.
    Steben M; Ouhoummane N; Rodier C; Sinyavskaya L; Brassard P
    J Med Virol; 2018 Mar; 90(3):592-598. PubMed ID: 28980715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
    Drolet M; Bénard É; Pérez N; Brisson M;
    Lancet; 2019 Aug; 394(10197):497-509. PubMed ID: 31255301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual prevalence and economic burden of genital warts in Korea: Health Insurance Review and Assessment (HIRA) service data from 2007 to 2015.
    Park YJ; Kim JM; Lee BR; Kim TH; Lee EG
    Epidemiol Infect; 2018 Jan; 146(2):177-186. PubMed ID: 29235433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reduced national incidence of anogenital warts in young Danish men and women after introduction of a national quadrivalent human papillomavirus vaccination programme for young women--an ecological study.
    Sandø N; Kofoed K; Zachariae C; Fouchard J
    Acta Derm Venereol; 2014 May; 94(3):288-92. PubMed ID: 24150529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017.
    Checchi M; Mesher D; Mohammed H; Soldan K
    Sex Transm Infect; 2019 Aug; 95(5):368-373. PubMed ID: 30723186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment.
    Guerra FM; Rosella LC; Dunn S; Wilson SE; Chen C; Deeks SL
    Vaccine; 2016 Sep; 34(39):4678-4683. PubMed ID: 27527815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal Trends in the Incidence of Anogenital Warts: Impact of Human Papillomavirus Vaccination.
    Naleway AL; Crane B; Smith N; Francisco M; Weinmann S; Markowitz LE
    Sex Transm Dis; 2020 Mar; 47(3):179-186. PubMed ID: 31880738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals.
    Nygård S; Nygård M; Orumaa M; Hansen BT
    Vaccine; 2023 Aug; 41(37):5469-5476. PubMed ID: 37516572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data.
    Thöne K; Horn J; Mikolajczyk R
    BMC Infect Dis; 2017 Aug; 17(1):564. PubMed ID: 28806926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of anogenital warts: epidemiological risk factors and real-life impact of human papillomavirus vaccination.
    Tyros G; Mastraftsi S; Gregoriou S; Nicolaidou E
    Int J STD AIDS; 2021 Jan; 32(1):4-13. PubMed ID: 33167803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health service utilisation for anogenital warts in Ontario, Canada prior to the human papillomavirus (HPV) vaccine programme introduction: a retrospective longitudinal population-based study.
    Guerra FM; Rosella LC; Dunn S; Wilson SE; Chen C; Deeks SL
    BMJ Open; 2016 Mar; 6(3):e009914. PubMed ID: 26966057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
    Ali H; Donovan B; Wand H; Read TR; Regan DG; Grulich AE; Fairley CK; Guy RJ
    BMJ; 2013 Apr; 346():f2032. PubMed ID: 23599298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
    Woestenberg PJ; King AJ; van der Sande MA; Donken R; Leussink S; van der Klis FR; Hoebe CJ; Bogaards JA; van Benthem BH; ;
    J Infect; 2017 Apr; 74(4):393-400. PubMed ID: 28126492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination Against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients.
    Woestenberg PJ; Guevara Morel AE; Bogaards JA; Hooiveld M; Schurink-van 't Klooster TM; Hoebe CJPA; van der Sande MAB; van Benthem BHB
    Clin Infect Dis; 2021 Jul; 73(2):291-297. PubMed ID: 32421775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a surveillance case definition for anogenital warts, Kaiser Permanente northwest.
    Naleway AL; Weinmann S; Crane B; Gee J; Markowitz LE; Dunne EF
    Sex Transm Dis; 2014 Aug; 41(8):496-500. PubMed ID: 25013978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in incidence of anogenital warts diagnoses after the introduction of human papillomavirus vaccination in Germany-an ecologic study.
    Mikolajczyk RT; Kraut AA; Horn J; Schulze-Rath R; Garbe E
    Sex Transm Dis; 2013 Jan; 40(1):28-31. PubMed ID: 23250300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.